Painreform is trading at $0.66, down 7.06% in pre-market, with no verified company-specific announcement linked to the decline.
- A November 3 term sheet with Dotz Nano was announced after the regular session, but available coverage does not connect it to this move.
- A shareholder petition seeking a special meeting and director changes was reported November 3; no source confirms it drove the decline.
- Major U.S. indices were higher; trading volume or activity details were unavailable.